Botanix Pharmaceuticals Limited
BXPHF
$0.25
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 123.00K | 126.50K | 557.40K | 556.20K | 123.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 123.00K | 126.50K | 557.40K | 556.20K | 123.20K |
| Cost of Revenue | 393.80K | 404.90K | 881.10K | 879.20K | 318.80K |
| Gross Profit | -270.80K | -278.40K | -323.70K | -323.00K | -195.60K |
| SG&A Expenses | 9.78M | 10.06M | 2.31M | 2.31M | 1.60M |
| Depreciation & Amortization | 364.30K | 374.60K | 21.10K | 21.10K | 2.70K |
| Other Operating Expenses | -- | -- | 133.50K | 133.20K | -- |
| Total Operating Expenses | 10.54M | 10.84M | 3.35M | 3.34M | 1.92M |
| Operating Income | -10.42M | -10.71M | -2.79M | -2.78M | -1.80M |
| Income Before Tax | -10.06M | -10.35M | -2.77M | -2.76M | -1.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.06M | -10.35M | -2.77M | -2.76M | -1.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.06M | -10.35M | -2.77M | -2.76M | -1.78M |
| EBIT | -10.42M | -10.71M | -2.79M | -2.78M | -1.80M |
| EBITDA | -10.05M | -10.34M | -2.77M | -2.76M | -1.80M |
| EPS Basic | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.82B | 1.82B | 1.56B | 1.56B | 1.44B |
| Average Diluted Shares Outstanding | 1.82B | 1.82B | 1.56B | 1.56B | 1.44B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
